scholarly journals Management of penoscrotal extramammary Paget disease: case series and review of the literature

2013 ◽  
Vol 20 (4) ◽  
pp. 311 ◽  
Author(s):  
P. Moretto ◽  
V.J. Nair ◽  
S. El Hallani ◽  
S. Malone ◽  
E. Belanger ◽  
...  
2020 ◽  
Vol 66 ◽  
pp. 270-276
Author(s):  
Anas Bouzbouz ◽  
Bushra Abdulhakeem ◽  
Rabii Laababsi ◽  
Sami Rouadi ◽  
Reda Abada ◽  
...  

2019 ◽  
Vol 12 (4) ◽  
pp. 189-193 ◽  
Author(s):  
Jonathan T. Kapke ◽  
Robert J. Schneidewend ◽  
Zeeshan A. Jawa ◽  
Chiang-Ching Huang ◽  
Jennifer M. Connelly ◽  
...  

2007 ◽  
Vol 73 (11) ◽  
pp. 1181-1187 ◽  
Author(s):  
Lesly A. Dossett ◽  
Lisa M. White ◽  
Dereck C. Welch ◽  
Alan J. Herline ◽  
Roberta L. Muldoon ◽  
...  

Colonic adenocarcinoma frequently complicates inflammatory bowel disease of the colon, but small bowel adenocarcinoma (SBA) is a rare complication of Crohn's disease (CD). We present two patients with SBA in CD and review the literature with regards to CD-related SBA. A 45-year-old male with a 17-year history of ileal CD presented with obstructive symptoms but no radiographic evidence of a mass. After laparoscopic ileocolectomy and repair of incidental ileosigmoid fistula, pathology showed a T3N0 adenocarcinoma within the ileal CD. Two years after his resection he was without evidence of disease. A 59-year-old male with a 15-year history of CD presented with an acute exacerbation. Small bowel follow through demonstrated a long ileal stricture for which he underwent an ileocolic resection. Postoperative pathology confirmed a T3N1 CD-related SBA. He died from metastatic cancer 3 months later. Review of the literature identified 154 cases of SBA complicating CD with several distinguishing features from de novo SBA. Patients with SBA and CD are, as a group, younger and more likely to be male. SBA is rarely diagnosed preoperatively in these patients, and has a poor prognosis due to its advanced stage at diagnosis.


Author(s):  
Grammatiki Katsikaki ◽  
Ioannis E. Dagklis ◽  
Petros Angelopoulos ◽  
Dimitrios Ntantos ◽  
Angeliki Prevezianou ◽  
...  

2016 ◽  
Vol 48 (8) ◽  
pp. 893-898 ◽  
Author(s):  
Lídia Roque Ramos ◽  
Christopher J. DiMaio ◽  
David B. Sachar ◽  
Ashish Atreja ◽  
Jean-Frédéric Colombel ◽  
...  

Author(s):  
Ahmad Al Bishawi ◽  
Hamad Abdel Hadi ◽  
Eman Elmekaty ◽  
Musaed Al Samawi ◽  
Arun Nair ◽  
...  

Remdesivir was the first antiviral agent to receive FDA authorization for severe COVID-19 management, which restricts its use with severe renal impairment due to concerns that active metabolites might accumulate, causing renal toxicities. With limited treatment options, available evidence on such patient groups is important to assess for future safety.


2017 ◽  
Vol 34 (5) ◽  
pp. e235-e240 ◽  
Author(s):  
Tina Ho ◽  
Lauren A.V. Orenstein ◽  
Markus D. Boos ◽  
Kevin P. White ◽  
Nicole Fett

2014 ◽  
Vol 2014 ◽  
pp. 1-7 ◽  
Author(s):  
Maheen Z. Abidi ◽  
Nayantara Coelho-Prabhu ◽  
James Hargreaves ◽  
Tim Weiland ◽  
Irminne Van Dyken ◽  
...  

Mucormycosis is a rare and often fatal invasive fungal infection mostly seen in immune-compromised individuals. A high index of clinical suspicion is necessary, so that effective preemptive therapy can be started, as timely intervention is crucial. In this series we present three cases of invasive mucormycosis in patients with underlying inflammatory bowel disease that had received therapy with immunomodulators prior to the infection. All three had varied clinical manifestations. We also review the literature of invasive mucormycosis in patients with inflammatory bowel disease.


Sign in / Sign up

Export Citation Format

Share Document